Glucose metabolism‐targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor‐induced drug‐tolerant persisters

In pathway‐targeted cancer drug therapies, the relatively rapid emergence of drug‐tolerant persisters (DTPs) substantially limits the overall therapeutic benefit. However, little is known about the roles of DTPs in drug resistance. In this study, we investigated the features of epidermal growth fact...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Sci
Autors principals: Kunimasa, Kei, Nagano, Tatsuya, Shimono, Yohei, Dokuni, Ryota, Kiriu, Tatsunori, Tokunaga, Shuntaro, Tamura, Daisuke, Yamamoto, Masatsugu, Tachihara, Motoko, Kobayashi, Kazuyuki, Satouchi, Miyako, Nishimura, Yoshihiro
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5497794/
https://ncbi.nlm.nih.gov/pubmed/28445002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13266
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars